PHILLANDAS T. THOMPSON

CIK 1661781 · See Remarks · last filed 2019-03-11

PHILLANDAS T. THOMPSON is a corporate insider who has filed 10 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for AVDL, was dated Mar 11, 2019. Across all open-market trades the lifetime net is +$215.5K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

2

Total Filings

10

Lifetime Open-Market Net

$215.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
AVADEL PHARMACEUTICALS PLC (AVDL) Delisted	See Remarks	113,671	$21.64	$2.46M	$104.5K	5	2019-03-11
AVADEL PHARMACEUTICALS PLC (FLML) Delisted	See Remarks	0	—	—	$111.0K	5	2017-01-03

Recent Filings

10 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2019-03-11	AVADEL PHARMACEUTICALS PLC (AVDL) Delisted	Grant (A)	+18,000	$0	EDGAR
2018-06-27	AVADEL PHARMACEUTICALS PLC (AVDL) Delisted	Buy (P)	+10,000	$57.7K	EDGAR
2017-12-14	AVADEL PHARMACEUTICALS PLC (AVDL) Delisted	Grant (A)	+18,000	$0	EDGAR
2017-09-14	AVADEL PHARMACEUTICALS PLC (AVDL) Delisted	Buy (P)	+5,000	$46.8K	EDGAR
2017-01-13	AVADEL PHARMACEUTICALS PLC (AVDL) Delisted	Grant (A)	+58,000	$0	EDGAR
2017-01-03	AVADEL PHARMACEUTICALS PLC (FLML) Delisted	Disp (D)	−58,000	$0	EDGAR
2017-01-03	AVADEL PHARMACEUTICALS PLC (FLML) Delisted	Grant (A)	+58,000	$0	EDGAR
2016-12-16	AVADEL PHARMACEUTICALS PLC (FLML) Delisted	Grant (A)	+18,000	$0	EDGAR
2016-08-12	AVADEL PHARMACEUTICALS PLC (FLML) Delisted	Grant (A)	+20,000	$0	EDGAR
2016-03-22	AVADEL PHARMACEUTICALS PLC (FLML) Delisted	Buy (P)	+10,000	$111.0K	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.